Keros Therapeutics Inc (KROS) Live Share Price, Invest From India

Keros Therapeutics Inc Stock Performance

as on April 25, 2026 at 2:08 am IST

Day's Low
Day's High
$11.34
Day's Price Range
$11.55
$11.54
1.73%
Downside
0.09%
Upside
52 Week's Low
52 Week's High
$10.42
52-Week Price Range
$22.55
$11.54
9.75%
Downside
95.41%
Upside

Keros Therapeutics Inc share price movements today

Previous Close: $11.56
Open: $11.45
Volume: 68.5K
Day's Low - High: $11.34 - $11.55
52 Week Low - High: $10.42 - $22.55

Keros Therapeutics Inc Historical Returns

1 Month Return: + 5.19 %
3 Month Return: -39.79 %
1 Year Return: -19.83 %
3 Year Return: -73.83 %
5 Year Return: 0 %

Keros Therapeutics Inc Stock Fundamentals & Key Indicators

Check Keros Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$228.7M

EPS (TTM)

-4.6733

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

5.03

Industry PE ratio

-3.902511848341232

PEG Ratio

EBITDA

72.1M

Revenue (TTM)

244.1M

Profit Margin

35.65%

Return On Equity TTM

19.90%

Keros Therapeutics Inc Stock Valuation

Track how Keros Therapeutics Inc P/E has moved over time to understand its valuation trends.

Keros Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-64.50x)

March 31, 2025

Industry (-3.90x)

April 24, 2026

Today (5.03x)

April 24, 2026

Highest (43.55x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 5.03x

Keros Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Keros Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Keros Therapeutics Inc	BUY	$228.7M	NA	5.03	35.65%
Alnylam Pharmaceuticals Inc	BUY	$41.4B	129.51%	133.3	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.3B	99.68%	28.57	32.94%
BeiGene, Ltd.	NA	$33.3B	NA	121.87	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	56.77%	17.99	31.41%

Stock Returns calculator for Keros Therapeutics Inc Stock including INR - Dollar returns

The Keros Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Keros Therapeutics Inc investment value today

Current value as on today

₹88,377

Returns

-₹11,623

(-11.62%)

Returns from Keros Therapeutics Inc Stock

-₹19,972 (-19.97%)

Dollar Impact

₹8,350 (+8.35%)

Analyst Recommendation on Keros Therapeutics Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Keros Therapeutics Inc. Average target price of $22.57

Keros Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Keros Therapeutics Inc.

What analysts predicted

48.87%UPSIDE

Target Price

$22.57

Current Price

$11.54

Analyzed by

16 Analysts

Target

$22.57

Keros Therapeutics Inc target price $22.57, a slight upside of 48.87% compared to current price of $11.54. According to 16 analysts rating.

Keros Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Keros Therapeutics Inc Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:23% versus previous 30 day period

Keros Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	3	211	18	14	0
Gross Profit	0	0	0	0	0	2	211	17	13	0
Operating Income	-43	-46	-48	-50	-58	-53	152	-39	-15	-26
EBITDA	-38	-39	-48	-50	-58	-29	152	-32	-8	-28
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-39	-40	-43	-45	-52	-45	158	-32	-8	-24
Income Tax Expense	0	3	0	-	-	0	10	-2	-1	-1
Net Income	-39	-40	-43	-45	-52	-46	148	-30	-7	-23
Net Profit Margin	-493000.00%	-28141.96%	-51944.58%	-122316.22%	-13648.45%	-1513.02%	70.27%	-168.96%	-51.04%	-6093.77%

Keros Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	10	10	2	20	20	0	3	244
Gross Profit	0	-7	0	20	-1	0	3	242
Operating Income	-1	-10	-46	-56	-114	-169	-210	70
EBITDA	0	-11	-44	-56	-104	-152	-185	72
Interest Expense	0	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	1	1
Income Before Tax	-1	-12	-45	-56	-104	-152	-187	91
Income Tax Expense	0	0	0	2	0	0	0	4
Net Income	-1	-12	-45	-58	-104	-152	-187	87
Net Profit Margin	-13.35%	-123.44%	-1814.44%	-292.26%	-523.40%	-101319.21%	-5277.55%	35.65%

Keros Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-40	-43	-45	-52	-46	148	-30	-7	-23
Operating Cash Flow	-25	-44	-39	-30	-46	161	-29	3	-27
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	69	156	3	155	75	0	0	0	-378
Change in Cash	43	111	-36	125	29	160	-30	3	-406

Keros Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-45	-58	-104	-152	-187	87
Operating Cash Flow	-15	-36	-62	-70	-124	-160	107
Investing Cash Flow	0	0	-1	-1	-2	-1	-1
Financing Cash Flow	0	296	28	120	178	391	-378
Change in Cash	-16	258	-34	49	51	229	-272

Global Institutional Holdings in Keros Therapeutics Inc

Funds	Holdings
State Street Corp	6.61%
ADAR1 Capital Management LLC	13.27%
Citadel Advisors Llc	2.4%
Morgan Stanley - Brokerage Accounts	2%
Nantahala Capital Management, LLC	1.83%

See all

Insights on Keros Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 49.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 127.0%
NEGATIVE IMPACT
Price Dip
In the last 3 months, KROS stock has moved down by -39.8%

About Keros Therapeutics Inc

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis; and elritercept to target TGF-ß signaling pathways to address diseases that arise from ineffective hematopoiesis in Phase 3 clinical trials for Myelodysplastic Syndromes and Phase 2 clinical trials for Myelofibrosis. The company has collaboration and license agreements with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept; and Takeda Pharmaceuticals U.S.A., Inc. to develop, manufacture, and commercialize elritercept and certain derivative compounds. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Organisation	Keros Therapeutics Inc
Headquarters	1050 Waltham Street, Lexington, MA, United States, 02421
Industry	Biotechnology
CEO	Dr. Jasbir S. Seehra Ph.D.
E-voting on shares	Click here to vote

Key Management of Keros Therapeutics Inc

Name	Title
Ms. Esther Cho J.D.	Chief Legal Officer & Secretary
Dr. Lorena Lerner Ph.D.	Chief Scientific Officer
Dr. Jasbir S. Seehra Ph.D.	President, CEO & Director
Mr. Keith C. Regnante MBA	Chief Financial Officer

FAQs

What is Keros Therapeutics Inc share price today?

Keros Therapeutics Inc share price today is $11.54 as on April 24, 2026 at 8:38 pm IST. Keros Therapeutics Inc share today touched a day high of $11.55 and a low of $11.34.

What is the 52 week high and 52 week low for Keros Therapeutics Inc share?

Keros Therapeutics Inc share touched a 52 week high of $22.55 on December 8, 2025 and a 52 week low of $10.42 on March 30, 2026. Keros Therapeutics Inc stock price today i.e. April 24, 2026 at 8:38 pm IST is trending at $11.54,which is 48.82% down from its 52 week high and 10.80% up from its 52 week low.

What is Keros Therapeutics Inc's market capitalisation today?

Keros Therapeutics Inc market capitalisation is $0.00T as on April 24, 2026 at 8:38 pm IST.

How to invest in Keros Therapeutics Inc Stock (KROS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Keros Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Keros Therapeutics Inc Shares that will get you 0.1300 shares as per Keros Therapeutics Inc share price of $11.54 per share as on April 24, 2026 at 8:38 pm IST.

What is the minimum amount required to buy Keros Therapeutics Inc Stock (KROS) from India?

Indian investors can start investing in Keros Therapeutics Inc (KROS) shares with as little as ₹94.228 or $1 (as of April 24, 2026 at 8:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Keros Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 8:38 pm IST). Based on Keros Therapeutics Inc share’s latest price of $11.54 as on April 24, 2026 at 8:38 pm IST, you will get 0.8666 shares of Keros Therapeutics Inc. Learn more about fractional shares .